Concepedia

Author

Hok Seon Kim

Research & Diagnostic Antibodies (United States)ORCID

Also Known As

Hok Seon Kim

15

Publications

1.3K

Citations

11

H-Index

38

Concepts

All Affiliations

Research & Diagnostic Antibodies (United States)PDL BioPharma (United States)
HS

About

Hok Seon Kim is an author at Research & Diagnostic Antibodies (United States) specializing in medicine, immunology, and antibody engineering.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

365

2

Engineering

2

2

83

3

Natural Sciences

2

2

26

4

Biochemistry

1

1

10

5

Biomedical Engineering

1

1

72

Hok Seon Kim

×

13

Publications

1.3K

Citations

11

H-Index

YearCitations

The Secreted Protein Discovery Initiative (SPDI), a Large-Scale Effort to Identify Novel Human Secreted and Transmembrane Proteins: A Bioinformatics Assessment

Hilary Clark, Austin Gurney, Evangeline Abaya,

Genome Research

2003

335

Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice

Megan Lo, Hok Seon Kim, Raymond K. Tong,

Journal of Biological Chemistry

2017

315

Amelioration of Type 2 Diabetes by Antibody-Mediated Activation of Fibroblast Growth Factor Receptor 1

Ai-Luen Wu, Ganesh Kolumam, Scott Stawicki,

Science Translational Medicine

2011

172

Cutting Edge: Novel Human Dendritic Cell- and Monocyte-Attracting Chemokine-Like Protein Identified by Fold Recognition Methods

M. Teresa Pisabarro, Beatrice Leung, Mandy Kwong,

The Journal of Immunology

2006

108

Sustained Brown Fat Stimulation and Insulin Sensitization by a Humanized Bispecific Antibody Agonist for Fibroblast Growth Factor Receptor 1/βKlotho Complex

Ganesh Kolumam, Mark Z. Chen, Raymond K. Tong,

EBioMedicine

2015

107

Isolation and Characterization of the B-Cell Marker CD20

James A. Ernst, Hong Li, Hok Seon Kim,

Biochemistry

2005

84

Contribution of Antibody Hydrodynamic Size to Vitreal Clearance Revealed through Rabbit Studies Using a Species-Matched Fab

Whitney Shatz-Binder, Philip E. Hass, Mary Mathieu,

Molecular Pharmaceutics

2016

72

Design and Pharmacokinetic Characterization of Novel Antibody Formats for Ocular Therapeutics

Kapil Gadkar, Cinthia V. Pastuskovas, Jennifer E. Le Couter,

Investigative Ophthalmology & Visual Science

2015

66

Susceptibility of Antibody CDR Residues to Chemical Modifications Can Be Revealed Prior to Antibody Humanization and Aid in the Lead Selection Process

XU An-kai, Hok Seon Kim, Samarkand Estee,

Molecular Pharmaceutics

2018

16

Evading pre-existing anti-hinge antibody binding by hinge engineering

Hok Seon Kim, Ingrid Kim, Linda Zheng,

mAbs

2016

14

Page 1